Dr. Benjamin G. Neel Sitting at Microscope in Lab

Expert Perspectives

Breakthrough Platform Unifies Targeted & Immune Therapies

Perlmutter Cancer Center director and co-creator of the HapImmune platform discusses the technology’s potential.
Dr. Jeffrey S. Weber

Advancing Science

A Personalized mRNA Vaccine Reduces Melanoma Recurrence Risk

In a phase 2 trial, pairing an mRNA vaccine with pembrolizumab improved relapse-free survival in advanced melanoma.
Surgical Resection of Urinary Bladder Papillary Carcinoma

Practice-Changing Medicine

A Mid-Treatment Pivot to Trimodal Therapy

Patient’s decision to forego radical cystectomy exemplifies opportunity to expand TMT as a treatment option.
Doctor Examines Real-Time Breast Imaging Result on Computer Screen, While Patient Is Imaged in Background

Advancing Science

AI Improves Breast Cancer Detection

Expanding their suite of AI tools for breast imaging, researchers develop a machine learning model for DCE-MRI.
Researcher Holding Rack of Test Tubes with Blood Samples

Advancing Science

Blood-Based Test Predicts Cancer Recurrence & Toxicity from Adjuvant Immunotherapy

Research test developed at Perlmutter Cancer Center pinpoints changes in a newly identified autoantibody panel.

Dr. Janice Mehnert

Practice-Changing Medicine

Accelerating Innovations in Early-Phase Oncology Trials

Perlmutter Cancer Center joins national collaborative to address unmet needs through innovative early-phase trials.
Load More